Pupil size and axial length affect near vision

Article

Small pupil size and short axial length predict good near vision after phacoemulsification and monofocal IOL implantation.

Small pupil size and short axial length predict good near vision after phacoemulsification and monofocal IOL implantation, claims the latest study in the Journal of Refractive Surgery.

The retrospective study, conducted by Dr D.H. Limet al., Department of Ophthalmology, Samsung Medical Centre, Seoul, Korea, involved 84 eyes of 84 patients who underwent cataract surgery with monofocal IOL implantation from October 2009 to April 2010. Eyes were identified as having good or poor near vision. Factors recorded included age, sex, IOL movement, axial length, pupil size, degree and type of astigmatism, IOL type, total aberration and higher-order aberrations (HOAs).

Good near vision was classified in 34 eyes and 50 eyes had poor near vision. All groups had a postoperative uncorrected visual acuity of more than 0.2 logMAR and a refractive error within ± 0.5 D of spherical equivalent.

Pupil size smaller than 2.6 mm and an axial length of less than 23.0 mm were inversely correlated with good near vision, compared to larger measurements after monofocal IOL implantation.

To read the abstract please click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.